Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

(S)-Bromoenol lactone

Copy Product Info
😃Good
Catalog No. T60832Cas No. 478288-94-7
Alias (S,E)-Bromoenol lactone, (S)-BEL

(S)-Bromoenol lactone ((S)-BEL) is a mechanism-based, irreversible inhibitor of calcium-independent phospholipase A2 (iPLA2). In contrast to its enantiomer (R)-BEL, (S)-BEL exhibits a preference for iPLA2γ (Group VIB), typically being about 10- to 100-fold more potent at inhibiting iPLA2γ than iPLA2β (Group VIA). This compound, used in conjunction with (R)-BEL, is a critical pharmacological tool for discriminating the specific functions of iPLA2β versus iPLA2γ in processes such as cellular signaling, arachidonic acid release, and smooth muscle contraction.

(S)-Bromoenol lactone

(S)-Bromoenol lactone

Copy Product Info
😃Good
Catalog No. T60832Alias (S,E)-Bromoenol lactone, (S)-BELCas No. 478288-94-7
(S)-Bromoenol lactone ((S)-BEL) is a mechanism-based, irreversible inhibitor of calcium-independent phospholipase A2 (iPLA2). In contrast to its enantiomer (R)-BEL, (S)-BEL exhibits a preference for iPLA2γ (Group VIB), typically being about 10- to 100-fold more potent at inhibiting iPLA2γ than iPLA2β (Group VIA). This compound, used in conjunction with (R)-BEL, is a critical pharmacological tool for discriminating the specific functions of iPLA2β versus iPLA2γ in processes such as cellular signaling, arachidonic acid release, and smooth muscle contraction.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
500 μg$113-In Stock
1 mg$19835 days35 days
5 mg$83335 days35 days
10 mg$1,32035 days35 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
(S)-Bromoenol lactone ((S)-BEL) is a mechanism-based, irreversible inhibitor of calcium-independent phospholipase A2 (iPLA2). In contrast to its enantiomer (R)-BEL, (S)-BEL exhibits a preference for iPLA2γ (Group VIB), typically being about 10- to 100-fold more potent at inhibiting iPLA2γ than iPLA2β (Group VIA). This compound, used in conjunction with (R)-BEL, is a critical pharmacological tool for discriminating the specific functions of iPLA2β versus iPLA2γ in processes such as cellular signaling, arachidonic acid release, and smooth muscle contraction.
Synonyms(S,E)-Bromoenol lactone, (S)-BEL
Chemical Properties
Molecular Weight317.18
FormulaC16H13BrO2
Cas No.478288-94-7
SmilesO=C1[C@H](C=2C3=C(C=CC2)C=CC=C3)CC/C(=C\Br)/O1
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy (S)-Bromoenol lactone | purchase (S)-Bromoenol lactone | (S)-Bromoenol lactone cost | order (S)-Bromoenol lactone | (S)-Bromoenol lactone chemical structure | (S)-Bromoenol lactone formula | (S)-Bromoenol lactone molecular weight